Name the university in Russia, where they produce the vaccine Sputnik 5 against Covid 19 virus
Answers
Answer:
Russia is set to roll out the world's first approved coronavirus vaccine amid scepticism about its effectiveness and safety after less than two months of human testing.
President Vladimir Putin announced on Tuesday that Russia had become the first country to grant regulatory approval to a COVID-19 vaccine, which showed "stable immunity" against the new coronavirus and had "passed all the necessary checks".
However, the vaccine, named "Sputnik V" in homage to the world's first satellite launched by the Soviet Union, has not yet completed its phase-three trial, which involves wide-scale testing with thousands of participants.
Across the globe, more than 200 vaccine candidates are being developed and trialled, with at least 24 in the human clinical trial phase, according to the World Health Organization (WHO).
Here is what we know so far about Russia's vaccine:
What is Sputnik V?
The "Sputnik V" is a vaccine developed by the Gamaleya research institute in coordination with the Russian defence ministry. It is based on a proven vaccine against adenovirus - the common cold.
The vaccine is expected to provide immunity from SARS-CoV-2, the virus that causes COVID-19, for up to two years, according to the Russian health ministry. But the results of the limited trials have yet to be made public.
The vaccine is administered in two doses and consists of two serotypes of human adenovirus, each carrying an S-antigen of the new coronavirus, which enter human cells and produce an immune response.
It is a so-called viral vector vaccine, meaning it employs another virus to carry the DNA encoding of the needed immune response into cells.
The platform used for the vaccine was developed by Russian scientists over 20 years and had formed the basis for several vaccines in the past, including those against Ebola.
Gamaleya's vaccine is based on similar technology to the coronavirus vaccine prototype developed by CanSino, a Chinese vaccine-making company.
Health Minister Mikhail Murashko has said clinical trials involving several thousand participants would follow.
The first batch of the vaccine will be made available for medical personnel in the next two weeks, he said on Wednesday.
The vaccine could be available for mass use in October, according to the country's health ministry.
hope it helps...
Sputnik V vaccine was developed at the Gamaleya Research Institute of Epidemiology and Microbiology, in Russia.
- Sputnik V is a one-shot vaccine that has shown credibly high efficacy against the Corona Virus and most of its variants including the Delta and the Omicron variants.
- It also acts as a booster and so one need not take any booster dozen after taking the Sputnik V shot.
- Its efficacy is as high as 80% against the normal variant and 70% against the Delta variant.
- Also as we know that the virus is most damaging for the older age groups, the Sputnik V shot provides an efficacy of 75% for the age group above 60 years.
#SPJ3